Copyright Reports & Markets. All rights reserved.

Global Cancer Drugs Market Insights and Forecast to 2026

Request for Sample of this report
Buy now

1 Study Coverage

  • 1.1 Cancer Drugs Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Cancer Drugs Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Cancer Drugs Market Size Growth Rate by Type
    • 1.4.2 Breast Cancer
    • 1.4.3 Blood Cancer
    • 1.4.4 Gastrointestinal Cancer
    • 1.4.5 Prostate Cancer
    • 1.4.6 Skin Cancer
    • 1.4.7 Lung Cancer
    • 1.4.8 Others
  • 1.5 Market by Application
    • 1.5.1 Global Cancer Drugs Market Size Growth Rate by Application
    • 1.5.2 Immunotherapy
    • 1.5.3 Targeted Therapy
    • 1.5.4 Chemotherapy
    • 1.5.5 Hormone Therapy
    • 1.5.6 Others
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Executive Summary

  • 2.1 Global Cancer Drugs Market Size, Estimates and Forecasts
    • 2.1.1 Global Cancer Drugs Revenue 2015-2026
    • 2.1.2 Global Cancer Drugs Sales 2015-2026
  • 2.2 Global Cancer Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
    • 2.2.1 Global Cancer Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.2.2 Global Cancer Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Cancer Drugs Competitor Landscape by Players

  • 3.1 Cancer Drugs Sales by Manufacturers
    • 3.1.1 Cancer Drugs Sales by Manufacturers (2015-2020)
    • 3.1.2 Cancer Drugs Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Cancer Drugs Revenue by Manufacturers
    • 3.2.1 Cancer Drugs Revenue by Manufacturers (2015-2020)
    • 3.2.2 Cancer Drugs Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Cancer Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Cancer Drugs Revenue in 2019
    • 3.2.5 Global Cancer Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Cancer Drugs Price by Manufacturers
  • 3.4 Cancer Drugs Manufacturing Base Distribution, Product Types
    • 3.4.1 Cancer Drugs Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Cancer Drugs Product Type
    • 3.4.3 Date of International Manufacturers Enter into Cancer Drugs Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Cancer Drugs Market Size by Type (2015-2020)
    • 4.1.1 Global Cancer Drugs Sales by Type (2015-2020)
    • 4.1.2 Global Cancer Drugs Revenue by Type (2015-2020)
    • 4.1.3 Cancer Drugs Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Cancer Drugs Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Cancer Drugs Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Cancer Drugs Revenue Forecast by Type (2021-2026)
    • 4.2.3 Cancer Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Cancer Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)

  • 5.1 Global Cancer Drugs Market Size by Application (2015-2020)
    • 5.1.1 Global Cancer Drugs Sales by Application (2015-2020)
    • 5.1.2 Global Cancer Drugs Revenue by Application (2015-2020)
    • 5.1.3 Cancer Drugs Price by Application (2015-2020)
  • 5.2 Cancer Drugs Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Cancer Drugs Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Cancer Drugs Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Cancer Drugs Price Forecast by Application (2021-2026)

6 North America

  • 6.1 North America Cancer Drugs by Country
    • 6.1.1 North America Cancer Drugs Sales by Country
    • 6.1.2 North America Cancer Drugs Revenue by Country
    • 6.1.3 U.S.
    • 6.1.4 Canada
  • 6.2 North America Cancer Drugs Market Facts & Figures by Type
  • 6.3 North America Cancer Drugs Market Facts & Figures by Application

7 Europe

  • 7.1 Europe Cancer Drugs by Country
    • 7.1.1 Europe Cancer Drugs Sales by Country
    • 7.1.2 Europe Cancer Drugs Revenue by Country
    • 7.1.3 Germany
    • 7.1.4 France
    • 7.1.5 U.K.
    • 7.1.6 Italy
    • 7.1.7 Russia
  • 7.2 Europe Cancer Drugs Market Facts & Figures by Type
  • 7.3 Europe Cancer Drugs Market Facts & Figures by Application

8 Asia Pacific

  • 8.1 Asia Pacific Cancer Drugs by Region
    • 8.1.1 Asia Pacific Cancer Drugs Sales by Region
    • 8.1.2 Asia Pacific Cancer Drugs Revenue by Region
    • 8.1.3 China
    • 8.1.4 Japan
    • 8.1.5 South Korea
    • 8.1.6 India
    • 8.1.7 Australia
    • 8.1.8 Taiwan
    • 8.1.9 Indonesia
    • 8.1.10 Thailand
    • 8.1.11 Malaysia
    • 8.1.12 Philippines
    • 8.1.13 Vietnam
  • 8.2 Asia Pacific Cancer Drugs Market Facts & Figures by Type
  • 8.3 Asia Pacific Cancer Drugs Market Facts & Figures by Application

9 Latin America

  • 9.1 Latin America Cancer Drugs by Country
    • 9.1.1 Latin America Cancer Drugs Sales by Country
    • 9.1.2 Latin America Cancer Drugs Revenue by Country
    • 9.1.3 Mexico
    • 9.1.4 Brazil
    • 9.1.5 Argentina
  • 9.2 Central & South America Cancer Drugs Market Facts & Figures by Type
  • 9.3 Central & South America Cancer Drugs Market Facts & Figures by Application

10 Middle East and Africa

  • 10.1 Middle East and Africa Cancer Drugs by Country
    • 10.1.1 Middle East and Africa Cancer Drugs Sales by Country
    • 10.1.2 Middle East and Africa Cancer Drugs Revenue by Country
    • 10.1.3 Turkey
    • 10.1.4 Saudi Arabia
    • 10.1.5 U.A.E
  • 10.2 Middle East and Africa Cancer Drugs Market Facts & Figures by Type
  • 10.3 Middle East and Africa Cancer Drugs Market Facts & Figures by Application

11 Company Profiles

  • 11.1 Bayer
    • 11.1.1 Bayer Corporation Information
    • 11.1.2 Bayer Description and Business Overview
    • 11.1.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Bayer Cancer Drugs Products Offered
    • 11.1.5 Bayer Related Developments
  • 11.2 GlaxoSmithKline
    • 11.2.1 GlaxoSmithKline Corporation Information
    • 11.2.2 GlaxoSmithKline Description and Business Overview
    • 11.2.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
    • 11.2.4 GlaxoSmithKline Cancer Drugs Products Offered
    • 11.2.5 GlaxoSmithKline Related Developments
  • 11.3 Novartis
    • 11.3.1 Novartis Corporation Information
    • 11.3.2 Novartis Description and Business Overview
    • 11.3.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
    • 11.3.4 Novartis Cancer Drugs Products Offered
    • 11.3.5 Novartis Related Developments
  • 11.4 Sanofi and Pfizer
    • 11.4.1 Sanofi and Pfizer Corporation Information
    • 11.4.2 Sanofi and Pfizer Description and Business Overview
    • 11.4.3 Sanofi and Pfizer Sales, Revenue and Gross Margin (2015-2020)
    • 11.4.4 Sanofi and Pfizer Cancer Drugs Products Offered
    • 11.4.5 Sanofi and Pfizer Related Developments
  • 11.5 Amgen
    • 11.5.1 Amgen Corporation Information
    • 11.5.2 Amgen Description and Business Overview
    • 11.5.3 Amgen Sales, Revenue and Gross Margin (2015-2020)
    • 11.5.4 Amgen Cancer Drugs Products Offered
    • 11.5.5 Amgen Related Developments
  • 11.6 Merck
    • 11.6.1 Merck Corporation Information
    • 11.6.2 Merck Description and Business Overview
    • 11.6.3 Merck Sales, Revenue and Gross Margin (2015-2020)
    • 11.6.4 Merck Cancer Drugs Products Offered
    • 11.6.5 Merck Related Developments
  • 11.7 Bristol-Myers Squibb
    • 11.7.1 Bristol-Myers Squibb Corporation Information
    • 11.7.2 Bristol-Myers Squibb Description and Business Overview
    • 11.7.3 Bristol-Myers Squibb Sales, Revenue and Gross Margin (2015-2020)
    • 11.7.4 Bristol-Myers Squibb Cancer Drugs Products Offered
    • 11.7.5 Bristol-Myers Squibb Related Developments
  • 11.8 Celgene Corporation
    • 11.8.1 Celgene Corporation Corporation Information
    • 11.8.2 Celgene Corporation Description and Business Overview
    • 11.8.3 Celgene Corporation Sales, Revenue and Gross Margin (2015-2020)
    • 11.8.4 Celgene Corporation Cancer Drugs Products Offered
    • 11.8.5 Celgene Corporation Related Developments
  • 11.9 Ariad Pharmaceuticals
    • 11.9.1 Ariad Pharmaceuticals Corporation Information
    • 11.9.2 Ariad Pharmaceuticals Description and Business Overview
    • 11.9.3 Ariad Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
    • 11.9.4 Ariad Pharmaceuticals Cancer Drugs Products Offered
    • 11.9.5 Ariad Pharmaceuticals Related Developments
  • 11.10 Eli Lilly
    • 11.10.1 Eli Lilly Corporation Information
    • 11.10.2 Eli Lilly Description and Business Overview
    • 11.10.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
    • 11.10.4 Eli Lilly Cancer Drugs Products Offered
    • 11.10.5 Eli Lilly Related Developments
  • 11.1 Bayer
    • 11.1.1 Bayer Corporation Information
    • 11.1.2 Bayer Description and Business Overview
    • 11.1.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Bayer Cancer Drugs Products Offered
    • 11.1.5 Bayer Related Developments
  • 11.12 Boehringer Ingelheim
    • 11.12.1 Boehringer Ingelheim Corporation Information
    • 11.12.2 Boehringer Ingelheim Description and Business Overview
    • 11.12.3 Boehringer Ingelheim Sales, Revenue and Gross Margin (2015-2020)
    • 11.12.4 Boehringer Ingelheim Products Offered
    • 11.12.5 Boehringer Ingelheim Related Developments
  • 11.13 Johnson and Johnson
    • 11.13.1 Johnson and Johnson Corporation Information
    • 11.13.2 Johnson and Johnson Description and Business Overview
    • 11.13.3 Johnson and Johnson Sales, Revenue and Gross Margin (2015-2020)
    • 11.13.4 Johnson and Johnson Products Offered
    • 11.13.5 Johnson and Johnson Related Developments
  • 11.14 Teva Pharmaceuticals
    • 11.14.1 Teva Pharmaceuticals Corporation Information
    • 11.14.2 Teva Pharmaceuticals Description and Business Overview
    • 11.14.3 Teva Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
    • 11.14.4 Teva Pharmaceuticals Products Offered
    • 11.14.5 Teva Pharmaceuticals Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)

  • 12.1 Cancer Drugs Market Estimates and Projections by Region
    • 12.1.1 Global Cancer Drugs Sales Forecast by Regions 2021-2026
    • 12.1.2 Global Cancer Drugs Revenue Forecast by Regions 2021-2026
  • 12.2 North America Cancer Drugs Market Size Forecast (2021-2026)
    • 12.2.1 North America: Cancer Drugs Sales Forecast (2021-2026)
    • 12.2.2 North America: Cancer Drugs Revenue Forecast (2021-2026)
    • 12.2.3 North America: Cancer Drugs Market Size Forecast by Country (2021-2026)
  • 12.3 Europe Cancer Drugs Market Size Forecast (2021-2026)
    • 12.3.1 Europe: Cancer Drugs Sales Forecast (2021-2026)
    • 12.3.2 Europe: Cancer Drugs Revenue Forecast (2021-2026)
    • 12.3.3 Europe: Cancer Drugs Market Size Forecast by Country (2021-2026)
  • 12.4 Asia Pacific Cancer Drugs Market Size Forecast (2021-2026)
    • 12.4.1 Asia Pacific: Cancer Drugs Sales Forecast (2021-2026)
    • 12.4.2 Asia Pacific: Cancer Drugs Revenue Forecast (2021-2026)
    • 12.4.3 Asia Pacific: Cancer Drugs Market Size Forecast by Region (2021-2026)
  • 12.5 Latin America Cancer Drugs Market Size Forecast (2021-2026)
    • 12.5.1 Latin America: Cancer Drugs Sales Forecast (2021-2026)
    • 12.5.2 Latin America: Cancer Drugs Revenue Forecast (2021-2026)
    • 12.5.3 Latin America: Cancer Drugs Market Size Forecast by Country (2021-2026)
  • 12.6 Middle East and Africa Cancer Drugs Market Size Forecast (2021-2026)
    • 12.6.1 Middle East and Africa: Cancer Drugs Sales Forecast (2021-2026)
    • 12.6.2 Middle East and Africa: Cancer Drugs Revenue Forecast (2021-2026)
    • 12.6.3 Middle East and Africa: Cancer Drugs Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter's Five Forces Analysis
  • 13.5 Primary Interviews with Key Cancer Drugs Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Cancer Drugs Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source
    • 16.2 Author Details

    Cancer Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Cancer Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

    Segment by Type, the Cancer Drugs market is segmented into
    Breast Cancer
    Blood Cancer
    Gastrointestinal Cancer
    Prostate Cancer
    Skin Cancer
    Lung Cancer
    Others

    Segment by Application, the Cancer Drugs market is segmented into
    Immunotherapy
    Targeted Therapy
    Chemotherapy
    Hormone Therapy
    Others

    Regional and Country-level Analysis
    The Cancer Drugs market is analysed and market size information is provided by regions (countries).
    The key regions covered in the Cancer Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
    The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
    Competitive Landscape and Cancer Drugs Market Share Analysis
    Cancer Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Cancer Drugs business, the date to enter into the Cancer Drugs market, Cancer Drugs product introduction, recent developments, etc.

    The major vendors covered:
    Bayer
    GlaxoSmithKline
    Novartis
    Sanofi and Pfizer
    Amgen
    Merck
    Bristol-Myers Squibb
    Celgene Corporation
    Ariad Pharmaceuticals
    Eli Lilly
    Hoffmann-La Roche
    Boehringer Ingelheim
    Johnson and Johnson
    Teva Pharmaceuticals

    Buy now